Nicotinamide Riboside Chloride

N/A

Report date: 2024/06/13 15:07:40

Base Information

Drug NameNicotinamide Riboside Chloride
Drug Alias NameNRCSRT-647
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-5 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-5
Therapy Area/IndicationsAtaxia Telangiectasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCornell UniversityDartmouth CollegeWashington University
China Registration ClassN/A

Develop Information

Active CompaniesNiagen Bioscience Inc
Inactive CompaniesN/A
Active IndicationsAtaxia Telangiectasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A